Literature DB >> 31366519

Androgen Receptor as a Biomarker of Oral Squamous Cell Carcinoma Progression Risk.

Cedna Tomasovic-Loncaric1, Aleksandra Fucic2, Ana Andabak3, Matej Andabak1, Marcello Ceppi4, Marco Bruzzone4, Danko Vrdoljak5, Vanja Vucicevic-Boras3.   

Abstract

BACKGROUND/AIM: Oral squamous cell carcinoma (OSCC) is a cancer with poor prognosis due to therapy resistance, locoregional recurrences, and distant metastases. There is on increased interest in profiling the androgen receptor (AR) in cancer biology. The aim of this study was to compare AR and Ki-67 levels in the neoplastic epithelium and stroma between non-metastatic and metastatic stages of OSCC. PATIENTS AND METHODS: Tissue specimens of 101 non-metastatic and 95 metastatic OSCC patients were analyzed by immunohistochemistry.
RESULTS: More than 20% of AR-positive cytoplasmic staining of OSCC epithelium was significantly associated with nuclear AR levels in the epithelium and increased AR levels in the stroma. In metastatic OSCC patients, Ki-67 was significantly higher than in non-metastatic OSCC patients.
CONCLUSION: More than 20% of AR-positive cytoplasmic staining in neoplastic OSSC epithelium is a significant predictor of OSCC progression risk. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Androgen receptor; Ki67; biomarker; metastasis; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31366519     DOI: 10.21873/anticanres.13593

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.

Authors:  Yumna Adnan; Syed Muhammad Adnan Ali; Muhammad Sohail Awan; Romana Idress; Muhammad Ozair Awan; Hasnain Ahmed Farooqui; Hammad Afzal Kayani
Journal:  PLoS One       Date:  2022-05-11       Impact factor: 3.752

2.  Comparison of Androgen Receptor, VEGF, HIF-1, Ki67 and MMP9 Expression between Non-Metastatic and Metastatic Stages in Stromal and Tumor Cells of Oral Squamous Cell Carcinoma.

Authors:  Lovorka Batelja-Vuletic; Cedna Tomasovic-Loncaric; Marcello Ceppi; Marco Bruzzone; Aleksandra Fucic; Karolina Krstanac; Vanja Boras Vucicevic
Journal:  Life (Basel)       Date:  2021-04-10

3.  LncRNA LINC01303 Promotes the Progression of Oral Squamous Cell Carcinomas via the miR-429/ZEB1/EMT Axis.

Authors:  Bo Sun; Xianyu Zheng; Weilong Ye; Pengcheng Zhao; Guowu Ma
Journal:  J Oncol       Date:  2021-12-06       Impact factor: 4.375

Review 4.  High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies.

Authors:  Lavinia Ghiani; Susanna Chiocca
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

5.  lncRNA TSPEAR-AS2, a Novel Prognostic Biomarker, Promotes Oral Squamous Cell Carcinoma Progression by Upregulating PPM1A via Sponging miR-487a-3p.

Authors:  Yi-Chao Xia; Jun Cao; Jing Yang; Ying Zhang; Yong-Sheng Li
Journal:  Dis Markers       Date:  2021-07-17       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.